{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T00:48:56Z","timestamp":1793753336823,"version":"4.6.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["202209ARB-490,310"],"award-info":[{"award-number":["202209ARB-490,310"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000082","name":"Cystic Fibrosis Canada","doi-asserted-by":"publisher","award":["558321"],"award-info":[{"award-number":["558321"]}],"id":[{"id":"10.13039\/501100000082","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000082","name":"Cystic Fibrosis Canada","doi-asserted-by":"publisher","award":["INVA-029"],"award-info":[{"award-number":["INVA-029"]}],"id":[{"id":"10.13039\/501100000082","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015751","name":"Qu\u00e9bec Consortium for Drug Discovery","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015751","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003151","name":"Nature et technologies","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003151","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["2022\\u201304028"],"award-info":[{"award-number":["2022\\u201304028"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["2020\\u201304811"],"award-info":[{"award-number":["2020\\u201304811"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009874","name":"Universit\u00e9 de Sherbrooke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009874","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006196","name":"Jet Propulsion Laboratory","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004489","name":"Mitacs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004489","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.bmc.2025.118493","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T05:10:19Z","timestamp":1763701819000},"page":"118493","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["In vitro and in vivo activity profiles of broad-spectrum bacterial ATP synthase inhibitors"],"prefix":"10.1016","volume":"133","author":[{"given":"Suzanne","family":"Chamberland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Larose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Millette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Langlois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"C\u00f4t\u00e9-Gravel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Brouillette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela Droppa","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renaud","family":"Binette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien A.","family":"Delbrouck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iryna","family":"Diachenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelkhalek Ben","family":"Jamaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad","family":"Normandin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Murza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Malouin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Luc","family":"Boudreault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2025.118493_bb0005","author":"O'Neill"},{"key":"10.1016\/j.bmc.2025.118493_bb0020","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1086\/514917","article-title":"Horizontal genetic exchange, evolution, and spread of antibiotic resistance in bacteria","volume":"27","author":"Maiden","year":"1998","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.bmc.2025.118493_bb0025","article-title":"A review on antibiotic resistance: alarm bells are ringing","volume":"9","author":"Zaman","year":"2017","journal-title":"Cureus"},{"key":"10.1016\/j.bmc.2025.118493_bb0035","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/s41429-023-00629-8","article-title":"Antibiotics in the clinical pipeline as of December 2022","volume":"76","author":"Butler","year":"2023","journal-title":"J Antibiot (Tokyo)"},{"issue":"13","key":"10.1016\/j.bmc.2025.118493_bb0040","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.3390\/molecules28134957","article-title":"The therapeutic value of Solanum steroidal (glyco)alkaloids: a 10-year comprehensive review","volume":"28","author":"Delbrouck","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2025.118493_bb0045","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02197-17","article-title":"Tomatidine is a lead antibiotic molecule that targets Staphylococcus aureus ATP synthase subunit C","volume":"62","author":"Lamontagne Boulet","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2025.118493_bb0050","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3389\/fmicb.2020.00805","article-title":"Bactericidal activity of the bacterial ATP synthase inhibitor tomatidine and the combination of tomatidine and aminoglycoside against persistent and virulent forms of Staphylococcus aureus","volume":"11","author":"Langlois","year":"2020","journal-title":"Front Microbiol"},{"key":"10.1016\/j.bmc.2025.118493_bb0055","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1126\/science.1106753","article-title":"A diarylquinoline drug active on the ATP synthase of mycobacterium tuberculosis","volume":"307","author":"Andries","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.bmc.2025.118493_bb0060","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nchembio884","article-title":"Diarylquinolines target subunit c of mycobacterial ATP synthase","volume":"3","author":"Koul","year":"2007","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.bmc.2025.118493_bb0065","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.bmc.2019.02.026","article-title":"3,5-Dialkoxypyridine analogues of bedaquiline are potent antituberculosis agents with minimal inhibition of the hERG channel","volume":"27","author":"Sutherland","year":"2019","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2025.118493_bb0070","doi-asserted-by":"crossref","first-page":"650","DOI":"10.3390\/antibiotics12040650","article-title":"Inhibitors of ATP synthase as new antibacterial candidates","volume":"12","author":"Mackieh","year":"2023","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.bmc.2025.118493_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115886","article-title":"From garden to lab: C-3 chemical modifications of tomatidine unveil broad-spectrum ATP synthase inhibitors to combat bacterial resistance","volume":"262","author":"Delbrouck","year":"2023","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118493_bb0080","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ejmech.2013.11.019","article-title":"Unraveling the structure\u2013activity relationship of tomatidine, a steroid alkaloid with unique antibiotic properties against persistent forms of Staphylococcus aureus","volume":"80","author":"Chagnon","year":"2014","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118493_bb0085","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3390\/molecules29020343","article-title":"Mode of action of tomatidine C3-diastereoisomers","volume":"29","author":"Langlois","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2025.118493_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2019.07.015","article-title":"Functional importance of \u03b1Asp-350 in the catalytic sites of Escherichia coli ATP synthase","volume":"672","author":"Raheem","year":"2019","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.bmc.2025.118493_bb0095","doi-asserted-by":"crossref","first-page":"13961","DOI":"10.1073\/pnas.1207912109","article-title":"Oligomycin frames a common drug-binding site in the ATP synthase","volume":"109","author":"Symersky","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bmc.2025.118493_bb0100","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1038\/s41467-020-16387-2","article-title":"Cryo-EM structures provide insight into how E. Coli F1Fo ATP synthase accommodates symmetry mismatch","volume":"11","author":"Sobti","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.bmc.2025.118493_bb0105","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41586-024-07605-8","article-title":"Inhibition of M. Tuberculosis and human ATP synthase by BDQ and TBAJ-587","volume":"631","author":"Zhang","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2025.118493_bb0110","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1500106","article-title":"Structure of the mycobacterial ATP synthase Fo rotor ring in complex with the anti-TB drug bedaquiline","volume":"1","author":"Preiss","year":"2015","journal-title":"Sci Adv"},{"key":"10.1016\/j.bmc.2025.118493_bb0115","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1128\/AAC.01393-08","article-title":"Selectivity of TMC207 towards mycobacterial ATP synthase compared with that towards the eukaryotic homologue","volume":"53","author":"Haagsma","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2025.118493_bb0120","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1002\/ejoc.202000051","article-title":"Gram-scale synthesis of tomatidine, a steroid alkaloid with antibiotic properties against persistent forms of Staphylococcus aureus","author":"Normandin","year":"2020","journal-title":"Eur J Org Chem"},{"key":"10.1016\/j.bmc.2025.118493_bb0125","doi-asserted-by":"crossref","first-page":"6008","DOI":"10.3390\/molecules26196008","article-title":"Concise large-scale synthesis of tomatidine, a potent antibiotic natural product","volume":"26","author":"Normandin","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2025.118493_bb0130","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ebiom.2019.02.061","article-title":"Quantitative contribution of efflux to multi-drug resistance of clinical Escherichia coli and Pseudomonas aeruginosa strains","volume":"41","author":"Cunrath","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bmc.2025.118493_bb0135","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1128\/AAC.02293-13","article-title":"Energy metabolism and drug efflux in mycobacterium tuberculosis","volume":"58","author":"Black","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.bmc.2025.118493_bb0140","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.vetmic.2004.04.008","article-title":"Mouse mastitis model of infection for antimicrobial compound efficacy studies against intracellular and extracellular forms of Staphylococcus aureus","volume":"101","author":"Brouillette","year":"2004","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.bmc.2025.118493_bb0145","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.3389\/fmicb.2019.02880","article-title":"Despite antagonism in vitro, Pseudomonas aeruginosa enhances Staphylococcus aureus colonization in a murine lung infection model","volume":"10","author":"Millette","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.bmc.2025.118493_bb0150","doi-asserted-by":"crossref","first-page":"4684","DOI":"10.1128\/AAC.00469-10","article-title":"Prevalence of antimicrobial-resistant pathogens in Canadian hospitals: results of the Canadian ward surveillance study (CANWARD 2008)","volume":"54","author":"Zhanel","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2025.118493_bb0155","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/genetics\/122.3.491","article-title":"Identification and characterization of a new gene of Escherichia coli K-12 involved in outer membrane permeability","volume":"122","author":"Sampson","year":"1989","journal-title":"Genetics"},{"key":"10.1016\/j.bmc.2025.118493_bb0160","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1128\/AAC.44.5.1387-1390.2000","article-title":"Contributions of the AmpC \u03b2-lactamase and the AcrAB multidrug efflux system in intrinsic resistance of Escherichia coli K-12 to \u03b2-lactams","volume":"44","author":"Mazzariol","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2025.118493_bb0165","series-title":"Clinical and Laboratory Standards Institute (CLSI). Methods for Dilution Antimicrobial Susceptibility Tests for bacteria that Grow Aerobically. 11th ed. CLSI standard M07","year":"2018"},{"key":"10.1016\/j.bmc.2025.118493_bb0170","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1021\/ed080p214","article-title":"An intuitive look at the relationship of Ki and IC50: a more general use for the Dixon plot","volume":"80","author":"Burlingham","year":"2003","journal-title":"J Chem Educ"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089625004341?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089625004341?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T08:40:43Z","timestamp":1781253643000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089625004341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":31,"alternative-id":["S0968089625004341"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2025.118493","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro and in vivo activity profiles of broad-spectrum bacterial ATP synthase inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2025.118493","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"118493"}}